Improving prostate cancer treatment for men with HIV
Official title: Optimizing Treatment of Prostate Cancer in Men living with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-10895472 · Data updated 2026-11-12
This study is looking at how having HIV impacts the treatment and results of prostate cancer in men with HIV, aiming to find the best ways to manage their cancer while keeping their overall health and quality of life in mind.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $669,206 |
| NIH project number | 5R01CA285342-02 |
| Project ID | NIH-10895472 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men living with HIV who have been diagnosed with localized prostate cancer.
✕Less likely to help
Patients with advanced prostate cancer or those not living with HIV may not benefit from this research.
What this research studies
This research investigates how HIV affects the treatment and outcomes of prostate cancer in men living with HIV. It aims to understand the unique challenges these patients face, including rapid cancer development and increased treatment side effects. By comparing different treatment strategies, the research seeks to identify the best approaches for managing localized prostate cancer while considering the overall health and quality of life of patients. The study will gather data to inform better decision-making for treatment options tailored to this population.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for prostate cancer in men living with HIV.
How similar studies have gone: While there has been limited research specifically on prostate cancer treatment in men with HIV, the study addresses a critical gap in knowledge that has not been previously explored in clinical trials.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sigel, Keith Magnus — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sigel, Keith Magnus
Related research
Other NIH-funded projects on the same topics.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Effects of ADT on motivation and emotion in prostate cancer patients
This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.
-
Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans
A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.
-
Ethical multimodal AI platform to improve prostate cancer detection with ultrasound
A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.
-
Characterizing epigenetic targets in prostate cancer to help AR-driven cancer
A research project at MD Anderson aims to understand how epigenetic factors shape androgen receptor signaling in prostate cancer to find new ways to treat resistant forms of the disease.
-
AR and RNA-binding in prostate cancer resistance
A cancer research grant exploring how the androgen receptor’s interaction with RNA may drive treatment resistance in prostate cancer, with potential to guide new therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.